IP Library Granted Patent US 12,467,897
Granted Patent B2
US 12,467,897 · App. 18/040,857 · Granted Nov 11, 2025

Electrophoresis device and biological substance recovery method

Inventors: Mima Ogawa (Tokyo, JP); Takahide Yokoi (Tokyo, JP)
Assignee: HITACHI HIGH-TECH CORPORATION
G01N27/44739C12N15/101
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,467,897
App. No.
18/040,857
Granted
Nov 11, 2025
Kind
B2
Abstract

An electrophoresis device is used to separate a biological substance using a separation medium. A recovery hole configured to recover the separated target biological substance is formed in an electrophoresis device, the recovery hole is configured to be capable of accommodating a solvent that can suspend the target biological substance, a buffer tank configured to accommodate a buffer solution is provided below the recovery hole, and a membrane is disposed between the recovery hole and the buffer tank.

Claims (21)

1 . An electrophoresis device configured to separate a biological substance with a separation medium, the electrophoresis device comprising:

a recovery hole configured to recover a separated target biological substance, the recovery hole being configured to be capable of accommodating a solvent capable of suspending the target biological substance;

a buffer tank configured to accommodate a buffer solution and provided below the recovery hole; and

a membrane disposed between the recovery hole and the buffer tank,

wherein the target biological substance is one type of ion.

2 . A biological substance recovery method using the electrophoresis device according to claim 1 , the biological substance recovery method comprising, before the target biological substance reaches the recovery hole:

removing the buffer solution in the recovery hole;

cleaning an inside of the recovery hole using a cleaning liquid; and

injecting the solvent into the recovery hole,

the biological substance recovery method further comprising recovering the target biological substance after the target biological substance reaches the recovery hole.

3 . A biological substance recovery method using the electrophoresis device according to claim 1 , the biological substance recovery method comprising:

removing a supernatant of the solvent in the recovery hole after the target biological substance reaches the recovery hole; and

recovering the target biological substance in the recovery hole after removing the supernatant.

4 . The biological substance recovery method according to claim 3 , wherein the removing the supernatant of the solvent is performed while continuously applying a voltage.

5 . The electrophoresis device according to claim 1 , wherein the buffer tank has an opening that is open upward and provided in a portion other than a portion where the membrane is disposed.

6 . The electrophoresis device according to claim 1 , further comprising a positive electrode and a negative electrode configured to apply a voltage, wherein the positive electrode is disposed at a lower position than the membrane.

7 . The electrophoresis device according to claim 6 , wherein the positive electrode is installed in a region that is not a region immediately below the membrane.

8 . The electrophoresis device according to claim 1 , further comprising an insulation that covers the separation medium and the recovery hole.

9 . The electrophoresis device according to claim 1 , further comprising an injection hole through which a sample containing the target biological substance is injected.

10 . The electrophoresis device according to claim 1 , wherein a permeability of the membrane with respect to the target biological substance is lower than a permeability of the membrane with respect to at least one other type of ion.

11 . The electrophoresis device according to claim 10 , wherein the membrane does not allow permeation of the target biological substance but allows permeation of the at least one other type ofion.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2023
From: OGAWA, MIMA; YOKOI, TAKAHIDE
To: HITACHI HIGH-TECH CORPORATION
Reel/Frame 062611/0892 →
Continuity (1)
Related Publication 20230349856A1 · Nov 2, 2023
References Cited (14)
US 5304488A · Cohen · 1994 [cited by examiner]
US 5538614A · Han · 1996 [cited by examiner]
US 5635045A · Alam · 1997 [cited by examiner]
US 9719961B2 · Sabin et al. · 2017 [cited by applicant]
US 20060134620A1 · Hirai · 2006 [cited by examiner]
US 20080057557A1 · Margalit · 2008 [cited by applicant]
US 20100270159A1 · Doucette · 2010 [cited by examiner]
JP 2004290109A · 2004 [cited by applicant]
JP 2010502962A · 2010 [cited by applicant]
JP 2011502243A · 2011 [cited by applicant]
WO WO2004048398A1 · 2004 [cited by applicant]
Englsih langauage translation of the Writen Opinion for international application No. PCT/JP2020/033293 , date of mailing Oct. 20, 2020. (Year: 2020). [cited by examiner]
International Search Report, mailed Oct. 20, 2020, for International Application No. PCT/JP2020/033293. [cited by applicant]
Written Opinion of the International Search Authority, mailed Oct. 20, 2020, for International Application No. PCT/JP2020/033293 (without English translation). [cited by applicant]